NIAID Resource-Related Research Projects (R24 Clinical Trial Not Allowed)

This notice of funding opportunity (NOFO) issued by the National Institute of Allergy and Infectious Diseases (NIAID) invites investigator-initiated Resource-Related Research Projects (R24) applications that may be critical to enhancing synergies among existing programs that address the specific mission of NIAID, as described above. Investigators are encouraged to visit this NIAID website for additional information about the research mission and high-priority research areas of the NIAID.

The purpose of the Resource-Related Research Projects (R24) are to support investigator-initiated research projects that will develop resources to serve biomedical research. A resource is a non-hypothesis-driven activity to provide data, materials, tools, or services that are essential to making the most timely, high quality, and cost-efficient progress in a field. The resource should be available to any qualified investigator, and should be highly quality controlled, replenishable, and not duplicate resources available commercially or through other sources.

As a first step, potential applicants are highly encouraged to contact the Scientific/Research Contact listed in Section VII for programmatic priorities.

Note: The Division of Microbiology and Infectious Diseases (DMID) supports a comprehensive suite of product development services and research tools, resources, and technologies to assist researchers that can be found here.

DMID encourages applications to develop unique non-clinical resources that can be utilized by the broader infectious disease research community and do not overlap with activities that may be supported under other mechanisms.

Note: The Division of Acquired Immunodeficiency Syndrome (DAIDS) encourages applications that propose to develop unique resources that can be utilized by the broader HIV research community, including data and bioinformatics resources and analytic tools, and that do not overlap with activities that may be supported under other mechanisms. DAIDS is particularly interested in applications that develop resources to support implementation science to end the HIV epidemic in the U.S.  

Note: The Division of Allergy, Immunology and Transplantation (DAIT) encourages applications that propose generation and distribution of unique reagents, clinical immunology patient registries, and data and bioinformatics resources (e.g., data compilation/aggregation, exchange, visualization, and analysis). DAIT also will support resources focused on extracting knowledge from data under the Findable, Accessible, Interoperable, and Reusable (FAIR) principles.

Note: The Chemical Countermeasures Research Program (CCRP) supports discovery research and early development of medical countermeasures (MCMs) to mitigate and treat both immediate and long-term effects of exposure to government-designated Chemicals of Concern during and after a public health emergency. The CCRP encourages applications that support the generation and distribution of nonclinical resources, such as unique reagents, non-animal model of human diseases/conditions after chemical injury (towards deeper understanding of a model system to improve the utilization, accessibility, and translational values for the research community), data repositories or knowledgebases (in support of FAIR principles), computational tools or software (to identify and prioritize Food and Drug Administration (FDA)-approved and late-stage investigational therapeutics for repurposing as MCMs), and related resources.